glass.bio blog

Compiling clinical reference data with Glass Bio

“I’ve sampled all these cells now, but what are they?”

Glass Bio helps you in two ways:

  1. We host Astral, a live catalog of over 300,000 cell clusters from thousands of samples. This catalog is easily searchable and will help you compare your samples to thousands of literature and clinical references.
  2. We expose a proprietary cell type annotation model that you can call on demand.

As a case study, we compare Sid Sijbrandij’s public osteosarcoma data with clinical references in Astral.

We start by to our platform, and then we with our annotation model - taking just a few clicks.

Once we have our sample annotated, we find relevant reference datasets in the catalog for each cell type, yielding dozens of relevant contrasts. From these contrasts, we calculate a spectrum of gene scores and find out where our samples place.

Macrophages

Grey dots represent catalog references. Red dots represent Sid’s T1, T2, and T3 osteosarcoma biopsy and surgery samples. All three patient samples exceed 93% of references for C1Q expression and 96% for inhibitory signaling.

In osteosarcoma cohorts, higher C1Q expression and C1Q-positive macrophage signatures were associated with longer overall survival. High inhibitory-gene expression points to macrophages that can dampen the immune response.

0.00.00.21.30.52.60.73.90.95.2C1Q TAMLog counts/10kInhibitory signalingLog counts/10kT1T2T3

IFN-response scores rise from 0.309 at T1 to 2.083 at T2 and 2.222 at T3. Both later samples exceed every selected macrophage reference. MHC-II presentation also rises. Together, these scores show a stronger inflammatory and antigen-presentation program in the later samples.

0.00.01.20.62.41.33.61.94.82.6IFN responseLog counts/10kMHC-II presentationLog counts/10kT1T2T3

T cells

Exhaustion-associated expression rises across T1, T2, and T3 without a parallel rise in cytotoxicity. This pattern points to sustained T-cell stimulation after immunotherapy.

0.00.00.30.80.61.50.92.31.23.0CytotoxicityLog counts/10kExhaustion-associatedLog counts/10kT1T2T3

Tumor candidates

Later samples show higher MHC-I and IFN scores. These cells express more of the machinery that displays tumor antigens to T cells, alongside a stronger interferon response.

0.00.00.30.80.61.50.92.31.23.1MHC-I presentationLog counts/10kIFN responseLog counts/10kT1T2T3